單價疫苗（EB病毒）市場按應用和地區分類

Monovaccine (Epstein - Barr virus) Market, By Application, By Geography

出版日期: 2026年01月22日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，單價疫苗（EB病毒）市值為 83.4 億美元，預計到 2033 年將達到 120.5 億美元，2026 年至 2033 年的複合年成長率為 5.40%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	83.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	5.40%	2033 年的預測值：	120.5億美元

EB病毒（EBV）感染人類B細胞，並在網狀內皮系統（RES）內擴散。已知此病毒可引起多種自體免疫疾病，包括多發性硬化症、乳糜瀉、全身性紅斑性狼瘡、幼年特發性關節炎、發炎性腸道疾病、類風濕性關節炎和第一型糖尿病。多項研究已將EB病毒與某些淋巴系統癌症和EB病毒聯繫起來。例如，辛辛那提兒童醫院醫學中心2018年的報告發現，EBV感染會增加多發性硬化症的風險。當人體遇到病毒和細菌等外來物質時，會利用B細胞產生抗體來對抗這些病原體。然而，在EB病毒感染中，病毒會入侵並控制B細胞。 EBV透過產生異常轉錄因子來調控基因表現，從而實現這一目標。

研究人員已證實，病毒轉錄因子EBNA2能夠結合人類基因組中與上述疾病相關的多個位點。 EB病毒也與多種人類癌症有關，包括伯基特淋巴瘤、鼻咽癌和移植後淋巴增生性疾病。然而，EB病毒導致不同類型癌症的確切原因目前仍在研究中。例如，在2017年發表於《婦科腫瘤學雜誌》的一項研究中，卡利卡里聯邦大學的研究人員報告稱，EB病毒陽性女性子宮頸癌的發生率是未感染EB病毒女性的四倍，這表明EB病毒感染會增加子宮頸癌的風險。

市場動態

許多大學都在積極進行研發活動，致力於開發新型單價疫苗。
例如，自2017年以來，堪薩斯大學工程學院和藥學院一直在研究人類免疫反應的遺傳學，以研發一種有效的EB病毒（EBV）疫苗。各機構加強對EBV新型疫苗的研究力度，預計將推動全球EB病毒疫苗市場的成長。
此外，與 EB 病毒相關的各種疾病的高發生率預計未來將增加對該病毒疫苗的需求。
例如，根據英國癌症研究中心2014年發表的數據，全球約有62,400例何傑金氏淋巴瘤病例，其中約28,600例與EB病毒相關。同一資訊來源估計，英國每年約有45%的何傑金氏淋巴瘤是由EB病毒引起的。
根據英國癌症研究中心2014年發布的數據，EB病毒是一種非常常見的病毒，會增加鼻咽癌的風險。據同一資訊來源稱，全球約有80,000例確診的鼻咽癌病例，其中約有78,100例與EB病毒有關。

本次調查的主要特點

本報告對全球單價疫苗（EB病毒）市場進行了詳細分析，並給出了市場規模（十億美元）。
它還重點介紹了各個細分市場的潛在商機，並解釋了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、區域前景以及主要企業採取的競爭策略的重要見解。
該研究根據以下參數對全球單疫苗（EB病毒）市場的主要企業進行了分析：公司概況、財務表現、產品系列、地理擴張、分銷策略、關鍵發展和策略以及未來計劃。
參與單一疫苗（EB病毒）研發的大學和機構包括英國癌症研究中心、美國國立衛生研究院 (NIH)、香港中文大學、Genocea Biosciences 公司、Dana-Farber 癌症研究所、德國癌症研究所和明尼蘇達大學。
本報告的研究結果將幫助負責人和經營團隊就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球單株疫苗（EB病毒）市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種策略矩陣輕鬆做出決策，這些矩陣用於分析全球單株疫苗（EB病毒）市場。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 8.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.40%	2033 Value Projection:	USD 12.05 Bn

Epstein-Barr virus (EBV) infects human B cells and spreads the infection throughout the entire reticuloendothelial system (RES). The virus is known to cause various autoimmune disorders including multiple sclerosis, celiac disease, systemic lupus erythematosus, juvenile idiopathic arthritis, inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes. Various research studies have linked Epstein-Barr virus to certain cancers of the lymphatic system and lupus. For instance, according to the report from the Cincinnati Children's Hospital Medical Center, in 2018, infection with the Epstein-Barr virus (EBV) increases the risk of developing multiple sclerosis. When the human body encounters foreign bodies such as virus or bacteria, it uses B-cells to produce antibodies to fight against these agents. However, in Epstein-Barr infections, the virus invades and takes control of B-cells. EBV invades B cells by producing abnormal transcription factors that regulate gene expression.

The researchers revealed that virus-derived EBNA2 transcription factor binds to several spots in the human genome that are linked to above mentioned diseases. Moreover, EBV is linked with several human cancers such as Burkitt's lymphoma, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disorder. However, the exact reason for EBV leading to different types of cancers is currently being studied by various researchers. For instance, according to the study published in Gynecologic Oncology Journal, 2017, researchers from the Federal University of Cariri stated that cervical carcinoma was four times more prevalent among EBV positive women than in women without EBV infection. This indicated that EBV infection increases the risk of cervical carcinoma.

Market Dynamics

Various universities are involved in frequent research and development activities for development of novel monovaccines.
For instance, since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Epstein - Barr virus or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV is expected to drive the global monovaccines (Epstein - Barr virus) market growth.
Furthermore, high prevalence of various diseases related to EBV virus is expected to rise demand for its vaccine in future.
For instance, according to data published by Cancer Research U.K. in 2014, around 62,400 cases of Hodgkin's lymphoma were recorded worldwide, out of which around 28,600 cases were associated with Epstein-Barr virus. According to the same source, it was estimated that EBV is responsible for an estimated 45% of Hodgkin's lymphoma in the U.K., annually.
According to data published by Cancer Research U.K. in 2014, EBV is a very common virus that can increase the risk of nasopharyngeal cancer. According to same source, there were around 80,000 cases of nasopharyngeal carcinoma worldwide, out of which around 78,100 cases were associated with Epstein-Barr virus.

Key features of the study

This report provides in-depth analysis of global monovaccine (Epstein-Barr Virus) market and provides market potential (US$ Billion)
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global monovaccine (Epstein-Barr Virus) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Universities and organizations involved in development of monovaccine (Epstein-Barr virus) includes Cancer Research U.K., National Institutes of Health, Chinese University of Hong Kong, Genocea Biosciences, Inc., Dana-Farber Cancer Institute, German Cancer Research Institute, and University of Minnesota
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global monovaccine (Epstein-Barr Virus) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global monovaccine (Epstein-Barr Virus) market

Market Segmentation

By Application
- Mononucleosis
- Endemic Burkitt's Lymphoma
- Hodgkin's Lymphoma
- Gastric Carcinomas
- Multiple sclerosis
- Nasopharyngeal Carcinoma
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Cancer Research UK
- National Institutes of Health
- Chinese University of Hong Kong
- Genocea Biosciences, Inc.
- Dana-Farber Cancer Institute
- German Cancer Research Institute
- University of Minnesota

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis

4. Global Monovaccine (Epstein-Barr Virus) Market, By Application, 2026 -2033 (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, 2026 - 2033
- Segment Trends
Mononucleosis
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Endemic Burkitt's Lymphoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Hodgkin's Lymphoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Gastric Carcinomas
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Multiple sclerosis
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
Nasopharyngeal Carcinoma
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)

5. Global Monovaccine (Epstein-Barr Virus) Market, By Region

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, For Region, 2026 - 2033
North America
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - U.S.
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Canada
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Latin America
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - Brazil
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Argentina
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Mexico
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Latin America
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Europe
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - U.K.
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Germany
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Italy
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Spain
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
France
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Russia
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Europe
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Asia Pacific
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country, 2026 - 2033
  - China
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
India
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Japan
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
ASEAN
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
South Korea
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Australia
- Country Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Asia Pacific
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Middle East
- Market Share Analysis, By Country/Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
  - GCC
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Israel
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Rest of Middle East
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Africa
- Market Share Analysis, By Country/Region, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
  - Northern Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
Central Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
South Africa
- Country/Region Trends
- Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)

6. Competitive Landscape

Heat Map Analysis
Company Profiles
- Cancer Research UK
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- National Institutes of Health
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Chinese University of Hong Kong
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Genocea Biosciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- Dana-Farber Cancer Institute
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- German Cancer Research Institute
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies
- University of Minnesota
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Strategies